[ Price : $8.95]
A Duane Morris client alert analyzes a recent FDA guidance on communicating scientific information to healthcare professionals abo...[ Price : $8.95]
Pfizer seeks full approval for current accelerated-approved Braftovi (encorafenib) in combination with cetuximab (Erbitux) and mFO...[ Price : $8.95]
FDA clears an EssilorLuxottica 510(k) for its over-the-counter Nuance Audio Glasses that provide an open-ear hearing solution inte...[ Price : $8.95]
FDA clears a Gyder Surgical 510(k) for the Gyder Hip System and its use in positioning the acetabular cup during hip replacement s...[ Price : $8.95]
FDA approves a Vertex Pharmaceuticals NDA for Journavx (suzetrigine), a first-in-class non-opioid pain drug for treating moderate ...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection revision entitled Labeling Requirements for Prescription Drugs...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection revision entitled Biosimilars User Fee Program.[ Price : $8.95]
An FDA alert advises healthcare providers about Fresenius Kabis Ivenix large-volume pumps and their increased chance of issuing a ...